Friday, 25 May 2007

FDA review also shows Glaxo diabetes drug risk

(Reuters) - FDA spokeswoman Julie Zawisza stressed that other data conflicted with that finding, and officials still were weighing whether to take any action.




A Cleveland Clinic analysis released Monday said the drug increased the chances of having a heart attack by 43 percent.


Read more at Reuters.com Government Filings News

No comments: